Why I Built This
A personal reflection on growing up South Asian, watching illness treated but never prevented — and why that needed to change.
"Growing up in a South Asian household, I watched family members and community elders receive diagnoses of Type 2 Diabetes and heart disease with a kind of resigned familiarity — as though it were simply the expected outcome of getting older."
What followed those diagnoses was always the same: a prescription for metformin, a referral to a cardiologist, instructions to "watch what you eat." The medical system did what it is designed to do — it managed the condition. But no one asked the more fundamental question: why is this happening so consistently, so early, in South Asian families?
The conversations were never about prevention. They were never about the specific ways South Asian biology — shaped by genetics, ancestral diet, and the physiological consequences of migration — creates a uniquely elevated metabolic risk profile. They were never about how rice and chai and late dinners interact with insulin sensitivity, or how visceral fat accumulates differently in South Asian bodies than in the populations for whom most clinical guidelines were originally developed.
As a South Asian student at Stanford, I carry that personal history into my academic work. I have seen the gap between what the medical literature documents about South Asian metabolic risk and what actually reaches South Asian families as actionable, culturally grounded guidance. That gap is what this platform exists to close.
Three Patterns I Kept Observing
Across families, community gatherings, and conversations with South Asian peers — the same dynamics appeared again and again.
A Culture of Reactive Medicine
In most South Asian households, health conversations begin only after a diagnosis. A family member is told they have Type 2 Diabetes — and the immediate response is medication management, not a root-cause conversation about why this happened and what could have prevented it.
Treatment Without Context
The clinical approach, while necessary, often does not account for the specific biological vulnerabilities South Asians carry — visceral fat accumulation at lower BMIs, insulin resistance patterns that develop earlier, and cardiovascular risk that emerges younger and at lower thresholds than standard clinical tools assume.
Generic Resources That Miss the Mark
The prevention literature and educational resources available to South Asian families routinely fail to address the foods they actually eat, the schedules they actually keep, the family structures they actually live within, and the cultural context in which health decisions are made.
Unique Biological Vulnerabilities South Asians Face
This is not about stigma or genetic determinism. It is about recognizing that the clinical tools, screening thresholds, and public health messages developed primarily from research on European-ancestry populations do not fully capture the risk profile of South Asians — and that this mismatch has real consequences.
Lower BMI Threshold
The American Diabetes Association recommends diabetes screening at a BMI of 23 kg/m² for Asian Americans — not the standard 25 kg/m² — because metabolic dysfunction often develops at lower body weights in South Asian populations.⁵
Visceral Adiposity
South Asians tend to accumulate a higher proportion of fat around internal organs (visceral fat) relative to subcutaneous fat, even when overall body weight appears low. This organ fat is metabolically active and directly linked to insulin resistance and cardiovascular risk.²
Insulin Secretion Patterns
Research suggests that South Asian beta-cell function — the pancreatic cells responsible for producing insulin — may be inherently more limited, contributing to younger-onset diabetes and faster progression of pre-diabetes.¹¹
Accelerated Cardiovascular Risk
The MASALA (Mediators of Atherosclerosis in South Asians Living in America) study documented that South Asians exhibit subclinical atherosclerosis and elevated 10-year cardiovascular risk at levels not fully predicted by standard risk calculators developed from predominantly European populations.⁹
Earlier Disease Onset
South Asians develop Type 2 Diabetes at a median age roughly 10 years younger than white European populations, and experience first myocardial infarction at significantly younger ages, as documented in the JAMA study of early MI in South Asians.¹⁰
Dietary Transition Effects
Migration to high-income countries introduces South Asians to ultra-processed foods, irregular eating schedules, and more sedentary environments — layered on top of an already elevated biological vulnerability, compounding risk.¹
A Note on This Evidence: The research cited above draws on peer-reviewed literature including the MASALA study, the Diabetes Prevention Program, the IDF Diabetes Atlas, ADA Standards of Care 2024, and studies of early myocardial infarction in South Asians. This platform synthesizes that evidence into accessible, community-facing guidance — it does not replace clinical advice.
The Goal of This Platform
This platform is not designed to replace physicians, dietitians, or cardiologists. It is designed to do something those clinical encounters rarely have time for: translate the evidence on South Asian metabolic risk into guidance that actually fits South Asian lives.
That means addressing real foods — rice, dosa, idli, biryani, chai, fried snacks, festival sweets — not abstract nutritional categories. It means acknowledging real schedules: students studying until 2 AM, professionals commuting for hours, families where dinner happens at 9 PM and everyone sits together.
It means respecting cultural context. South Asian health habits are shaped by family, by community, by tradition, by religion. Effective prevention guidance must work within that context, not demand that people abandon it.
Above all, this platform exists because the conversation about prevention should begin decades before the diagnosis — and it should begin in language that South Asian communities can actually recognize as their own.
What the Platform Covers
Who This Platform Is For
Built for South Asians at every stage of life — before, during, and after a diagnosis enters the family.
South Asian Students
Managing academics, stress, irregular sleep, and cafeteria food — while carrying a higher baseline metabolic risk.
Young Professionals
Long work hours, desk jobs, irregular meals, and early career stress are all documented metabolic risk factors.
Families
Prevention is a family project. When one person understands the risk, the conversation changes for the whole household.
Community Spaces
Temples, student organizations, and cultural associations are where health messaging can reach people before a diagnosis does.
A Note on Scope
This platform is a public health education initiative, not a clinical research study or intervention trial. It does not provide individualized medical advice. The goal is to ensure that South Asian individuals and families have access to prevention-focused, culturally grounded health information — and to encourage earlier, more informed conversations with their healthcare providers.
The information presented here is grounded in peer-reviewed literature and established public health guidelines. Where South Asian-specific evidence exists, it is prioritized. Where it is limited, the platform acknowledges that limitation directly.
Selected References
Sattar, N., and Gill, J.M.R. (2015). Type 2 diabetes in migrant South Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol. 3, 1004–1016.
Shah, A., and Kanaya, A.M. (2014). Diabetes and associated complications in the South Asian population. Curr. Cardiol. Rep. 16, 476.
International Diabetes Federation (2021). IDF Diabetes Atlas, 10th ed.
Palaniappan, L., et al. (2018). South Asian cardiovascular disease and cancer risk. J. Community Health 43, 1100–1114.
American Diabetes Association (2024). Standards of Care in Diabetes—2024. Diabetes Care 47(Suppl 1), S20–S42.
Bhopal, R.S., et al. (2014). Lifestyle intervention in South Asians at high risk of type 2 diabetes. Lancet Diabetes Endocrinol. 2, 218–227.
Knowler, W.C., et al. (2002). Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403.
Kandula, N.R., et al. (2014). Cardiovascular disease risk and subclinical atherosclerosis in South Asians: MASALA Study. J. Am. Heart Assoc. 3, e001117.
Joshi, P., et al. (2007). Risk factors for early myocardial infarction in South Asians. JAMA 297, 286–294.
Siddiqui, M.K., et al. (2022). Young-onset diabetes in Asian Indians. Diabetologia 65, 1018–1029.
This platform was created by Mahesh Pujyam, Stanford University. It is intended for educational purposes only and does not constitute medical advice. Readers are strongly encouraged to consult a qualified healthcare provider for any personal health decisions.